Your search for ‘Smart & Biggar’ returned 2,495 results

On March 14, 2018, the Discipline Committee of the Ontario College of Pharmacists found that two directors of Costco pharmacies committed acts of professional misconduct ...

On February 27, 2018, the federal budget was tabled in the House of Commons. It announced the creation of an Advisory Council on the Implementation of National Pharmacare ...

The Board will hold a public hearing (on a date to be determined no later than February 27, 2019) to determine whether Horizon Therapeutics Canada is selling ...

The Patented Medicine Prices Review Board (PMPRB) has released its 7th edition CompassRX report, Annual Public Drug Plan Expenditure Report for 2019/20.

As previously reported, the Federal Court of Appeal dismissed Apotex's appeal from a decision holding that the claims of a patent relating to lisdexamfetamine (Shire's VYVANSE)...

Scott MacKendrick and Andrew McIntosh's article "2023's Procedural Developments in IP Litigation" was published in the Toronto Law Journal.

In the October/November issue of The Trademark Lawyer magazine, Cynthia Rowden talks about the Canadian Trademarks Act...

The September 2017 amendments to Canada's Patented Medicines Regulations introduced a new pharmaceutical patent linkage litigation scheme that more closely mirrors the US Hatch-Waxman system. This detailed comparison chart examines the similarities and differences between these two regulatory frameworks, highlighting key distinctions that remain despite the convergence.

Carmela De Luca coauthors article in Molecular Diagnosis & Therapy published by Springer Nature, "Gene Patents in Canada: Is There a New Legal Landscape?"

On November 2, 2015, the CBSA released an updated version of its D Memorandum on Copyright and Trademarks (D19-4-1).

As we previously reported, the Canadian Intellectual Property Office (CIPO) has not issued patents since July 2, 2024. According to CIPO's updated roadmap, patent granting should resume on August 20, 2024.

In H. Lundbeck v Canada (Commissioner of Patents), 2021 FC 1394, the Court granted an application to amend a patent record to remove inventors and a co-owner.

Join François Larose and Christie Bates as they discuss changes affecting the use of trademarks in a language other than French in Québec, their practical effects, and what companies and individuals doing business in...

In this peer reviewed editorial for Informa Healthcare, Carmela De Luca discusses a recent agreement between Merck and The Medicines Patent Pool to license intellectual property relating to pediatric formulations of its integrase HIV drug.

As previously reported, the Federal Court of Appeal (FCA) dismissed Millennium Pharmaceuticals and Janssen's appeal from a decision granting Teva's claim for...

François Larose authors article on amendments to Québec's language laws and the impact on provincial and federally regulated businesses in Québec, published in Landslide magazine, a publication of the American Bar Association.

This informative podcast breaks down the key developments of AI in chemistry and explores the nuances of intellectual property in the field of Chemical AI.

On October 26, 2017, the Federal Minister of Health tabled the 2016 Annual Report of the PMPRB with the Clerks of the House of Commons and the Senate.